Affordable Access

deepdyve-link deepdyve-link
Publisher Website

[Prognostic significance of Ph-positive acute lymphoblastic leukemia].

Authors
Type
Published Article
Journal
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Publication Date
Volume
35
Issue
2
Pages
109–113
Identifiers
DOI: 10.3760/cma.j.issn.0253-2727.2014.02.011
PMID: 24606650
Source
Medline
License
Unknown

Abstract

allo-HSCT was an optimal choice for Ph⁺ALL patients. Imatinib-based therapy could increase CR rate, maintain CR duration and decrease relapse, resulting in more chance of HSCT. Imatinib improved the outcomes of Ph⁺ALL patients who were not eligible for HSCT.

Statistics

Seen <100 times